Hypogammaglobulinemia following non-myeloablative allogeneic stem cell transplant correlates with chimerism.

被引:0
|
作者
Bolwell, BJ [1 ]
Pohlman, B [1 ]
Sobecks, R [1 ]
Andresen, S [1 ]
Rybicki, L [1 ]
Kuczkowski, E [1 ]
Jarvis, J [1 ]
Koennecke, J [1 ]
Bernhard, L [1 ]
Ostendorf, H [1 ]
Bell, K [1 ]
Serafino, S [1 ]
Theil, K [1 ]
Kalaycio, M [1 ]
机构
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5183
引用
收藏
页码:353B / 353B
页数:1
相关论文
共 50 条
  • [1] Non-myeloablative allogeneic stem cell transplant: Achievements and perspectives
    Saito, T
    Mineishi, S
    EXPERIMENTAL ONCOLOGY, 2001, 23 (01): : 4 - 10
  • [2] Kinetics of engraftment in non-myeloablative allogenic peripheral blood stem cell transplant: An analysis of hematopoietic-lineage chimerism.
    Childs, R
    Clave, E
    Bahceci, E
    Hensel, N
    Barrett, J
    BLOOD, 1998, 92 (10) : 520A - 520A
  • [3] Allogeneic stem cell transplantation using non-myeloablative transplant regimens
    Körbling, M
    Khouri, I
    HIGH-DOSE THERAPY AND TRANSPLANTATION OF HAEMATOPOIETIC STEM CELLS, 2000, : 175 - 184
  • [4] Post-transplant lymphoproliferative disorder following non-myeloablative allogeneic stem cell transplantation
    Snyder, MJ
    Stenzel, TT
    Lagoo, AS
    Rizzieri, DA
    Chao, N
    Buckley, PJ
    Gong, JZ
    LABORATORY INVESTIGATION, 2003, 83 (01) : 253A - 253A
  • [5] Post-transplant lymphoproliferative disorder following non-myeloablative allogeneic stem cell transplantation
    Snyder, MJ
    Stenzel, TT
    Lagoo, AS
    Rizzieri, DA
    Chao, N
    Buckley, PJ
    Gong, JZ
    MODERN PATHOLOGY, 2003, 16 (01) : 253A - 253A
  • [6] Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients
    Narreddy, S.
    Mellon-Reppen, S.
    Abidi, M. H.
    Klein, J. L.
    Peres, E.
    Heilbrun, L. K.
    Smith, D.
    Alangaden, G.
    Chandrasekar, P. H.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (01) : 3 - 10
  • [7] Donor erythroid chimerism in mice after non-myeloablative allogeneic stem cell transplantation.
    Iannone, R
    Luznik, L
    Engstrom, LW
    Fuchs, EJ
    BLOOD, 1999, 94 (10) : 320B - 321B
  • [8] Risk for cytomegalovirus infection following non-myeloablative allogeneic stem cell transplantation
    Nachbaur, D
    Gunsilius, E
    Haun, M
    Larcher, C
    Gastl, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S96 - S97
  • [9] Allogeneic non-myeloablative peripheral-blood stem cell transplant in solid tumors
    Peccatori, J
    Bregni, M
    TUMORI, 2002, : S32 - S33
  • [10] Non-myeloablative allogeneic stem cell transplant in a patient with refractory systemic lupus erythematosus
    Lu, Q
    Lu, L
    Niu, X
    Guo, Y
    Parino, GR
    Liu, D
    BONE MARROW TRANSPLANTATION, 2006, 37 (10) : 979 - 981